Clinical Trial

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Name: Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma — clinical trial record (NCT07183852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GoTIL-01

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the feasibility, safety and tolerability of locoregional or systemic administration of autologous tumor infiltrating lymphocytes in patients with metastatic melanoma

Trial Details

NCT Number	NCT07183852
Lead Sponsor	Vastra Gotaland Region
Conditions	Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma
Enrollment	18 participants
Start Date	2026-03
Primary Completion	2028-03 (estimated)
Study Completion	2033-03 (estimated)
Updated on ClinicalTrials.gov	2025-09-19